OPAL Fuels Inc. OPAL Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price at other companies

Tarsus Pharmaceuticals, Inc.TARS

$47.13+56.3%

Espey Manufacturing & Electronics Corp.ESP

5.4+13.4%

CB Financial ServicesCBFV

$22.65-0.4%

Microbot MedicalMBOT

$1.65+66.7%

WaFd, Inc.WAFD

$7.53+36.9%

American Battery Technology CompanyABAT

$1.90—

Other financials

Income statement

See full

Revenue$73.4M-14.1%

Operating income-$4.8M-149%

Net income-$5.6M-536%

EPS (diluted)-$0.09-800%

Balance sheet

See full

Cash & equivalents$137.0M+205%

Total debt$475.5M+59.2%

Total equity$8.2M-85.6%

Total assets$1.1B+19.9%

Cash flow

See full

Operating cash flow$12.9M-56.5%

CapEx$24.4M+111%

Free cash flow-$11.5M-163%

Valuation

See full

Market cap$66.79M-15.3%

Enterprise value$405.35M+10.5%

P/E2.3×—

P/S0.2×0.0×

Profitability

See full

Operating margin1.3%-3.7pp

Net margin8.8%—

FCF margin-18.9%-1.1pp

Returns & leverage

See full

Return on equity90.4%—

Debt / equity57.9×+52.6×

Current ratio2.2×+1.1×

Where this comes from

Reported directly by OPAL Fuels Inc. in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: OPAL Fuels Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about OPAL Fuels Inc.'s share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OPAL Fuels Inc.'s share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price?: OPAL Fuels Inc. (OPAL) reported share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price of $2.46 in Q1 2026.